Viewing Study NCT02020369


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-02-27 @ 10:34 AM
Study NCT ID: NCT02020369
Status: COMPLETED
Last Update Posted: 2017-06-14
First Post: 2013-12-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors
Sponsor: rEVO Biologics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemophilia A With Inhibitors View
None Hemophilia B With Inhibitors View
Keywords: